Abstract:SESSION TITLE: Chest Infections: Bacterial SESSION TYPE: Original Investigation Poster PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM PURPOSE: Acinetobacter baumannii (Ab) is a global emerging bacterium resulting in nosocomial infections such as pneumonia, meningitis, bacteremia especially in intensive care units. Since Ab is resistant to almost all conventional antibiotics, the development of vaccine is one of the most promising and cost-effective strategies to prevent infections. In this study, we sought to investigate whether small protein A (SmpA) and Phospholipase D (PLD) were potential target to elicit protective immunity against A. baumannii infections. METHODS: After schedule immunized with antigens in dose gradient, the IgG titer in serum were measured to obtain an appropriate dose for vaccine. The mice induced to diabetic models were divided into 4 groups immunized SmpA, PLD, SmpA and PLD separately in optimal dose, and one group as a control. All mice received A. Baumannii aerosolized infection after immunization. Then serum and lung tissue were harvested to identify the efficacy of the active immunization. Survival cure was observed in mice received immunized serum following with a lethal infection to identify the efficacy of the passive immunization. RESULTS: Immunization with SmpA and PLD both produces a high level of IgG responses to A. baumannii. After immunized with optimal dose of SmpA and PLD, bacterial burden and pulmonary infiltration of inflammatory cells a pneumonia mice model. The immunization with SmpA and PLD also mediates both the cytokine level in BALF and in serum. The antisera from immunization mice can improve the survival curve in mice received lethal infections. CONCLUSIONS: We identified SmpA and PLD as valuable antigen candidates for the development of an effective vaccine and PLD were also valuable to prepare antisera to control A. baumannii infections. CLINICAL IMPLICATIONS: Our study may indicated a new way used in the treatment and prophylaxis of A.baumannii infection DISCLOSURE: The following authors have nothing to disclose: Haitao li, Pinhua Pan No Product/Research Disclosure Information

Small Protein A and Phospholipase D Immunization Serves a Protective Role in a Mouse Pneumonia Model of Acinetobacter Baumannii Infection

A Combination of Small Protein a (smpa) and Phospholipase D (PLD) Immunization Plays a Protective Role in Mice Pneumonia Model of Acinetobacter Baumannii Infection

Immunization With A Zmpb-Based Protein Vaccine Could Protect Against Pneumococcal Diseases In Mice

Protection Against Pneumococcal Infection Elicited By Immunization With Glutamyl Trna Synthetase, Polyamine Transport Protein D And Sortase A

Protection Elicited by Nasal Immunization with Pneumococcal Surface Protein A (pspa) Adjuvanted with Bacterium-Like Particles Against Streptococcus Pneumoniae Infection in Mice

Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia

Immunization with recombinant Streptococcus pneumoniae PgdA protects mice against lung invasion

The Cloning,expression and Possible Immune Protection Mechanism of Acinetobacter Baumannii A1S1969 Outer Membrane Protein

Protective Efficacy of a Genetic Subunit Bacterin against Actinobacillus pleuropneumoniae in Mice

Specific Humoral Immune Response Induced by Propionibacterium Acnes Can Prevent Actinobacillus Pleuropneumoniae Infection in Mice

Immunoprotective Efficacy of Six in Vivo-Induced Antigens Against Actinobacillus Pleuropneumoniae As Potential Vaccine Candidates in Murine Model.

A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model

Protective Efficacy and Immunologic Mechanism of the Recombinant Subunit Vaccine Against Actinobacillus Pleuropneumoniae in Mice

AAV-vectored expression of monospecific or bispecific monoclonal antibodies protects mice from lethal Pseudomonas aeruginosa pneumonia

Development and Evaluation of an Immunoinformatics-Based Multi-Peptide Vaccine against Acinetobacter baumannii Infection

Identification of proteins of Propionibacterium acnes for use as vaccine candidates to prevent infection by the pig pathogen Actinobacillus pleuropneumoniae

Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments

A Combinatorial Vaccine Containing Inactivated Bacterin and Subunits Provides Protection Against Actinobacillus Pleuropneumoniae Infection in Mice and Pigs

Role of Immunodeficiency in Acinetobacter Baumannii Associated Pneumonia in Mice.

A Multiepitope Peptide, Romp22, Encapsulated in Chitosan-PLGA Nanoparticles As a Candidate Vaccine Against Acinetobacter Baumannii Infection

A Novel PspA Protein Vaccine Intranasal Delivered by Bacterium-Like Particles Provides Broad Protection Against Pneumococcal Pneumonia in Mice